Skip to main content
Explore URMC

URMC Logo

menu

Publications

2018 | 2017 | 2016 | 2015 | 2014 | Archived

2018, Sept
Nogales A, Martinez-Sobrido L, Chiem K, Topham DJ, DeDiego ML
Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
PMID: 30021892

2018, Sept
DeDiego ML, Chiem K, Topham DJ
Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
PMID: 30224200

2018, Sept
Davis AKF, McCormick K, Gumina ME, Petrie JG, Martin ET, Xue KS, Bloom JD, Monto AS, Bushman FD, Hensley SE
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo.
PMID: 30045982

2018, August
Topham DJ, Nguyen P, Sangster MY
Pandemic influenza vaccines: what they have taught us about B cell immunology.
PMID: 29957457

2018, August
Richards KA, Treanor JJ, Nayak JL, Sant AJ
Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B Virus-Specific CD4+ T-Cell Repertoire.
PMID: 29762692

2018, August
Pardi N, Parkhouse K, Kirkpatrick E, McMahon M, Zost SJ, Mui BL, Tam YK, Karikó K, Barbosa CJ, Madden TD, Hope MJ, Krammer F, Hensley SE, Weissman D
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies.
PMID: 30135514

2018, August
Guthmiller JJ, Wilson PC
Harnessing immune history to combat influenza viruses.
PMID: 29890370

2018, August
DiPiazza AT, Richards KA, Liu WC, Albrecht RA, Sant AJ
Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection.
PMID: 30151589

2018, July
Sant AJ, DiPiazza AT, Nayak JL, Rattan A, Richards KA
CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.
PMID: 29944766

2018, July
Albrecht RA, Liu WC, Sant AJ, Tompkins SM, Pekosz A, Meliopoulos V, Cherry S, Thomas PG, Schultz-Cherry S
Moving Forward: Recent Developments for the Ferret Biomedical Research Model.
PMID: 30018107

2018, July
Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, Hensley SE, Grad YH
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
PMID: 29471464

2018, July
Zhang H, Henry C, Anderson CS, Nogales A, DeDiego ML, Bucukovski J, Martinez-Sobrido L, Wilson PC, Topham DJ, Miller BL
Crowd on a Chip: Label-Free Human Monoclonal Antibody Arrays for Serotyping Influenza.
PMID: 29985597

2018, June
Garretson TA, Petrie JG, Martin ET, Monto AS, Hensley SE
Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
PMID: 29861178

2018, May
Lewnard JA, Cobey S
Immune History and Influenza Vaccine Effectiveness.
PMID: 29883414

2018, May
Babu TM, Perera R, Wu JT, Fitzgerald T, Nolan C, Cowling BJ, Krauss S, Treanor JT, Peiris M
Population Serologic Immunity to human and avian H2N2 viruses in the United States and HongKong for Pandemic Risk Assessment.
PMID: 29762672

2018, April
Krammer F, Fouchier RAM, Eichelberger MC, Webby RJ, Shaw-Saliba K, Wan H, Wilson PC, Compans RW, Skountzou I, Monto AS
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
PMID: 29615508

2018, April
Richards KA, DiPiazza AT, Rattan A, Knowlden ZAG, Yang H, Sant AJ
Diverse Epitope Specificity, Immunodominance Hierarchy, and Functional Avidity of Effector CD4T Cells Established During Priming Is Maintained in Lung After Influenza A Virus Infection.
PMID: 29681900

2018, April
DiPiazza A, Laniewski N, Rattan A, Topham DJ, Miller J, Sant AJ
CD4 T cell epitope specificity and cytokine potential are preserved as cells transition from the lung vasculature to lung tissue following influenza infection.
PMID: 29669836

2018, April
Sant AJ, Richards KA, Nayak J
Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.
PMID: 29621639

2018, April
Chen YQ, Wohlbold TJ, Zheng NY, Huang M, Huang Y, Neu KE, Lee J, Wan H, Rojas KT, Kirkpatrick E, Henry C, Palm AE, Stamper CT, Lan LY, Topham DJ, Treanor J, Wrammert J, Ahmed R, Eichelberger MC, Georgiou G, Krammer F, Wilson PC
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
PMID: 29625056

2018, Mar
Nogales A, Piepenbrink MS, Wang J, Ortega S, Basu M, Fucile CF, Treanor JJ, Rosenberg AF, Zand MS, Keefer MC, Martinez-Sobrido L, Kobie JJ
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.
PMID: 29531320

2018, Mar
Rodriguez L, Reedy S, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L
Development of a novel equine influenza virus live-attenuated vaccine.
PMID: 29331866

2018, Feb
Anderson CS, McCall PR, Stern HA, Yang H, Topham DJ
Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.
PMID: 29433425

2018, Feb
Chauché C, Nogales A, Zhu H, Goldfarb D, Ahmad Shanizza AI, Gu Q, Parrish CR, Martínez-Sobrido L, Marshall JF, Murcia PR
Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1.
PMID: 29237841